Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹76.25.
30 Oct: open ₹77.77, high ₹77.77, low ₹76.60
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹277 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.89
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 6,475
Lyka Labs share news and announcements
1,492 announcements, routine notices left out, newest first. Page 10 of 30.
Aug 2022
3 Aug · Results
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)2 Aug · Meeting
1 Aug · Board meeting
Meeting on 8 Aug 2022: quarterly results and amalgamation
Jul 2022
19 Jul · No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Statement Of Investor Complaints For The Quarter Ended June 2022
Jun 2022
2 Jun · Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
2 Jun · Related Party Transaction
May 2022
31 May · Full And Final Payment Of Outstanding RSF 1 Facility And TL 2 Facility
21 May · Results
Apr 2022
19 Apr · Revised Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosures Requirements) Regulation, 2015
14 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements), 2015 For The Half Year Ended 31St March, 2022
14 Apr · Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosures Requirements) Regulation, 2015
12 Apr · No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Statement Of Investor Complaints For The Quarter Ended March 202212 Apr · Legal
The exchange asked on 11 Apr 2022